We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+11%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$6.83B
AUM Growth
+$439M
Cap. Flow
-$277M
Cap. Flow %
-4.05%
Top 10 Hldgs %
26.62%
Holding
140
New
27
Increased
39
Reduced
39
Closed
23

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$127M
2
ANAB icon
AnaptysBio
ANAB
+$76M
3
ARNA
Arena Pharmaceuticals Inc
ARNA
+$62.1M
4
TSM icon
TSMC
TSM
+$59.5M
5
LKQ icon
LKQ Corp
LKQ
+$45.9M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$89.2M
2
CNC icon
Centene
CNC
+$80.2M
3
HOLX
Hologic
HOLX
+$75.2M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
+$65.8M
5
BAX icon
Baxter International
BAX
+$63.9M

Sector Composition

Rank Sector Weight
1 Healthcare 49.61%
2 Technology 13.09%
3 Communication Services 5.22%
4 Consumer Discretionary 2.37%
5 Financials 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ESPR
26
DELISTED
Esperion Therapeutics
ESPR
$87.4M 1.28%
1,970,134
-490,023
-20% -$22.5M
CRM icon
27
Salesforce
CRM
$152B
$87.1M 1.28%
547,686
-176,545
-24% -$26.2M
MOH icon
28
Molina Healthcare
MOH
$10.6B
$85M 1.25%
571,571
+33,609
+6% +$4.29M
PBYI icon
29
Puma Biotechnology
PBYI
$399M
$84.9M 1.24%
1,851,638
+254,855
+16% +$12.3M
MMSI icon
30
Merit Medical Systems
MMSI
$4.7B
$82.8M 1.21%
1,346,963
-108,653
-7% -$6.24M
DBX icon
31
Dropbox
DBX
$7.72B
$77M 1.13%
2,868,767
+1,339,078
+88% +$38.7M
MDCO
32
DELISTED
Medicines Co
MDCO
$76.6M 1.12%
2,561,640
+472,643
+23% +$17.8M
SPOT icon
33
Spotify
SPOT
$105B
$73.4M 1.08%
406,165
+59,655
+17% +$10.9M
BSX icon
34
Boston Scientific
BSX
$68.3B
$73.4M 1.08%
1,907,622
+590,502
+45% +$20.6M
DATA
35
DELISTED
Tableau Software, Inc.
DATA
$73.4M 1.08%
657,129
+66,671
+11% +$7.19M
HCA icon
36
HCA Healthcare
HCA
$90.8B
$72.2M 1.06%
519,159
-3,186
-0.6% -$397K
MSGS icon
37
Madison Square Garden
MSGS
$9.5B
$69.7M 1.02%
309,790
+88,639
+40% +$19.7M
RVTY icon
38
Revvity
RVTY
$12.4B
$67.5M 0.99%
693,791
-468,026
-40% -$40.2M
AMZN icon
39
Amazon
AMZN
$2.45T
$64.8M 0.95%
646,860
+45,720
+8% +$4.3M
AAPL icon
40
Apple
AAPL
$5T
$63.6M 0.93%
1,126,512
+666,408
+145% +$34.7M
TSM icon
41
TSMC
TSM
$1.96T
$63.5M 0.93%
+1,437,247
New +$59.5M
XBI icon
42
PUT
State Street SPDR S&P Biotech ETF
XBI
$10B
$62.2M 0.91%
+648,700
New +$62.9M
BOLD
43
DELISTED
Audentes Therapeutics, Inc
BOLD
$61.5M 0.9%
1,554,139
+1,128,757
+265% +$42.1M
UNH icon
44
UnitedHealth
UNH
$388B
$60.1M 0.88%
225,793
-76,895
-25% -$20M
CLVS
45
DELISTED
Clovis Oncology, Inc.
CLVS
$56.6M 0.83%
1,927,928
-409,297
-18% -$15.8M
AMN icon
46
PUT
AMN Healthcare
AMN
$1.36B
$54M 0.79%
+987,100
New +$56.5M
RHT
47
DELISTED
Red Hat Inc
RHT
$52.9M 0.78%
388,407
+250,773
+182% +$35.9M
XYZ
48
Block Inc
XYZ
$48.9B
$52.1M 0.76%
525,793
-149
-0% -$11.5K
APTX
49
DELISTED
Aptinyx Inc. Common Stock
APTX
$49.5M 0.73%
1,754,679
+374,763
+27% +$9.11M
ISRG icon
50
Intuitive Surgical
ISRG
$128B
$49.4M 0.72%
258,294
-3,687
-1% -$655K
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2018 Portfolio in Review

As of Q3 2018, PFM Health Sciences held 140 positions worth $6.83B, up 6.9% from $6.39B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

PFM Health Sciences withdrew a net $277M in Q3 2018, closing 23 positions and reducing 39 holdings. Its most notable exit was Baidu, an estimated $89.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 49% a quarter earlier, followed by Technology and Communication Services.

Against the trend, PFM Health Sciences opened a new position in Allergan plc worth $131M.

  • PFM Health Sciences's largest Q3 2018 buy was Allergan plc: 689,949 shares worth $131M.
  • PFM Health Sciences added most to AnaptysBio in Q3 2018, an estimated $76M increase.
  • PFM Health Sciences's biggest Q3 2018 reduction was Endocyte, Inc. Common Stock, cutting an estimated $65.8M.
  • PFM Health Sciences fully exited Baidu in Q3 2018, selling an estimated $89.2M.
  • PFM Health Sciences's ten largest holdings make up 27% of its $6.83B portfolio in Q3 2018.
  • PFM Health Sciences opened 27 new positions and closed 23 in Q3 2018.
  • PFM Health Sciences's portfolio value rose 6.9% quarter-over-quarter to $6.83B.

Based on PFM Health Sciences's 13F filing for Q3 2018, filed 13 Nov 2018.